Celldex Therapeutics sell Barclays PLC
Start price
17.12.25
/
50%
€21.80
Target price
17.12.26
€20.43
Performance (%)
41.10%
Price
24.07.26
€30.68
Summary
This prediction is currently active. The price for Celldex Therapeutics has massively increased, which is bad news for the SELL prediction by Barclays_PLC. This prediction currently runs until 17.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 0.590% | 0.590% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.82
08.05.26
08.05.26
€40.93
08.05.27
08.05.27
5.73%
24.07.26
24.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.16
20.04.26
20.04.26
€38.28
20.04.27
20.04.27
4.49%
24.07.26
24.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
47.88%
24.07.26
24.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
31.34%
24.07.26
24.07.26